EUVIMEDEUVIMED entdecken
Crossref

Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT

Sungmin Woo iD, Daniel Freedman, Anton S Becker, Doris Leithner, Charlotte Charbel, Marius E Mayerhoefer, Kent P Friedman, Angela Tong, David R Wise, Samir S Taneja, Michael J Zelefsky, Hebert Alberto Vargas

Abdominal Radiology · 2025

DOI: 10.1007/s00261-025-04948-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Sungmin Woo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, NYU Langone Health, New York, USA. sungmin.woo@nyulangone.org. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Magnetic Resonance Imaging, Multimodal Imaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To explore pragmatic approaches integrating MRI and PSMA-PET/CT for evaluating extraprostatic extension (EPE) of prostate cancer (PCa). METHODS: Consecutive patients with newly-diagnosed PCa that underwent multiparametric MRI and PSMA-PET/CT, followed by radical prostatectomy in 2021-2024 were included. Imaging parameters assessed on both modalities were: size, length of capsular contact (LCC), Likert scales (MRI EPE grade/PSMA Likert scale), PI-RADS/PRIMARY scores, and SUVmax. Three pragmatic integrated approaches were tested: (1) Integration of Likert scales (positive if either or both MRI and PSMA-PET/CT were positive); (2) P score (framework combining PI-RADS + PRIMARY); and (3) combining MRI morphological information with PSMA-PET/CT functional information (upgrading suspicion of lesions with LCC below cutoff if SUVmax>12). Diagnostic performance was tested with receiver operating characteristic (ROC) curves and compared using DeLong and McNemar tests. RESULTS: 67 men (median age, 66 years) with EPE in 76.1% (51/67) were included. Area under ROC curves (AUC) were 0.61-0.82; MRI-based LCC yielded the highest AUC 0.82 (0.71-0.92) with cutoff of ≥ 1.7 cm. Integrated Likert scale (MRI EPE grade/PSMA Likert scale) showed sensitivity of 80.4% (41/51) and specificity of 31.3% (5/16). P score (PI-RADS/PRIMARY) demonstrated sensitivity of 31.3% (16/51) and specificity of 87.5% (14/16). Combining morphological MRI information with functional PSMA-PET/CT yielded sensitivity and specificity of 80.4% (41/51) and 81.2% (13/16), respectively, which demonstrated significantly higher sensitivity but non-significantly different specificity compared with MRI-based LCC alone (66.7% [34/51, p = 0.02] and 87.5% [14/16, p > 0.99]). This approach upgraded suspicion in 8 patients with LCC 12 among which 87.5% (7/8) were corrected upgraded and had pathological EPE. CONCLUSION: Several pragmatic approaches were explored for integrating MRI and PSMA-PET/CT to assess EPE in PCa. Combining morphological information from MRI and PSMA expression on PET/CT demonstrated good diagnostic performance and may be a simple pragmatic integrated method that can be used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyMagnetic Resonance ImagingMultimodal ImagingHumansMaleAgedMiddle AgedRetrospective StudiesNeoplasm InvasivenessProstatectomyMultiparametric Magnetic Resonance ImagingGlutamate Carboxypeptidase IIRadiopharmaceuticals

Stichwörter der Autor:innen

Extraprostatic extensionMagnetic resonance imagingPositron emission tomographyProstate cancerProstate specific membrane antigen

Substanzen

Glutamate Carboxypeptidase IIRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, NYU Langone Health, New York, USA. sungmin.woo@nyulangone.org.
  • Department of Radiology, NYU Langone Health, New York, USA.
  • Department of Medicine, Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA.
  • Department of Urology, NYU Langone Health, New York, USA.
  • Department of Radiation Oncology, NYU Grossman School of Medicine, New York, USA.

ORCID-Profile: Sungmin Woo

Zitieren

APA

Woo, S., Freedman, D., Becker, A. S., Leithner, D., Charbel, C., Mayerhoefer, M. E., Friedman, K. P., Tong, A., Wise, D. R., Taneja, S. S., Zelefsky, M. J., & Vargas, H. A. (2025). Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT. Abdominal Radiology. https://doi.org/10.1007/s00261-025-04948-2

Vancouver

Woo S, Freedman D, Becker AS, Leithner D, Charbel C, Mayerhoefer ME, et al. Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT. Abdominal Radiology. 2025. doi:10.1007/s00261-025-04948-2

BibTeX
@article{Woo2025,
  author = {Woo, Sungmin and Freedman, Daniel and Becker, Anton S and Leithner, Doris and Charbel, Charlotte and Mayerhoefer, Marius E and Friedman, Kent P and Tong, Angela and Wise, David R and Taneja, Samir S and Zelefsky, Michael J and Vargas, Hebert Alberto},
  title = {Evaluating extraprostatic extension of prostate cancer: pragmatic integration of MRI and PSMA-PET/CT},
  journal = {Abdominal Radiology},
  year = {2025},
  doi = {10.1007/s00261-025-04948-2}
}
Kostenlos starten →